---
title: "This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290195064.md"
description: "Wall Street analysts initiated coverage on several stocks Thursday. Raymond James rated Terreno Realty (TRNO) Underperform. HC Wainwright gave Relmada Therapeutics (RLMD) a Buy with a $12 target. Goldman Sachs initiated Talen Energy (TLN) and Constellation Energy (CEG) with Buy and Neutral ratings, setting targets of $499 and $305 respectively. BofA Securities rated Immix Biopharma (IMMX) a Buy with a $27 target."
datetime: "2026-06-18T11:45:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290195064.md)
  - [en](https://longbridge.com/en/news/290195064.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290195064.md)
---

# This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Raymond James analyst David Rodgers initiated coverage on **Terreno Realty Corp** (NYSE:TRNO) with an Underperform rating. Terreno Realty shares closed at $63.86 on Wednesday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Andres Y. Maldonado initiated coverage on **Relmada Therapeutics Inc** (NASDAQ:RLMD) with a Buy rating and announced a price target of $12. Relmada Therapeutics shares closed at $6.60 on Wednesday. See how other analysts view this stock.
-   Goldman Sachs analyst Carly Davenport initiated coverage on **Talen Energy Corp** (NASDAQ:TLN) with a Buy rating and announced a price target of $499. Talen Energy shares closed at $409.81 on Wednesday. See how other analysts view this stock.
-   B of A Securities analyst Tazeen Ahmad initiated coverage on **Immix Biopharma Inc** (NASDAQ:IMMX) with a Buy rating and announced a price target of $27. Immix Biopharma shares closed at $9.13 on Wednesday. See how other analysts view this stock.
-   Goldman Sachs analyst Carly Davenport initiated coverage on **Constellation Energy Corp** (NASDAQ:CEG) with a Neutral rating and announced a price target of $305. Constellation Energy shares closed at $267.17 on Wednesday. See how other analysts view this stock.

Considering buying TLN stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md)
- [TRNO.US](https://longbridge.com/en/quote/TRNO.US.md)
- [TLN.US](https://longbridge.com/en/quote/TLN.US.md)
- [RLMD.US](https://longbridge.com/en/quote/RLMD.US.md)
- [CEG.US](https://longbridge.com/en/quote/CEG.US.md)
- [CEGX.US](https://longbridge.com/en/quote/CEGX.US.md)
- [RJF.US](https://longbridge.com/en/quote/RJF.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [ADAR1 Capital Management LLC Grows Stock Position in Relmada Therapeutics, Inc. $RLMD](https://longbridge.com/en/news/294166619.md)
- [Relmada Therapeutics names Bipin Dalmia chief business officer](https://longbridge.com/en/news/294066297.md)
- [This Analyst Just Cut Its Price Target on SNDK Stock. Here's Why.](https://longbridge.com/en/news/293654906.md)
- [Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Short Interest Update](https://longbridge.com/en/news/294357729.md)
- [Terreno Realty (TRNO) Lease Momentum Keeps Valuation In Focus](https://longbridge.com/en/news/293806587.md)